Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

OCTREOTIDE ACET 50 MCG/ML VIAL

octreotide acetate
$2.6422per ML

Strength

50 ug/mL

Manufacturer

Heritage Pharmaceuticals Inc.

NDC

23155068741

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

INTRAVENOUS; SUBCUTANEOUS

Last Updated

4/22/2026

Active Ingredients

OCTREOTIDE ACETATE

Approval Type

Generic (ANDA)

FDA Application

ANDA204669

On Market Since

5/25/2022

Pharmacological Classes

Somatostatin Analog
Somatostatin Receptor Agonists

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+0.8%

1Y

+0.8%

3Y

N/A

5Y

N/A

All

-1.7%

Generic Alternatives

1 alternative • Same active ingredient

OCTREOTIDE ACET 50 MCG/ML VIAL
Generic
25021046301•Sagent Pharmaceuticals
$2.6422

Related Drugs

Same classification

OCTREOTIDE ACET 50 MCG/ML VIAL
Generic
00641617410•Hikma Pharmaceuticals USA Inc.
$2.6422
per ML
OCTREOTIDE ACET 100 MCG/ML VL
Generic
00641617510•Hikma Pharmaceuticals USA Inc.
$2.8912
per ML
OCTREOTIDE ACET 100 MCG/ML VL
Generic
63323037601•Fresenius Kabi USA, LLC
$2.8912
per ML
OCTREOTIDE ACET 100 MCG/ML VL
Generic
63323037604•Fresenius Kabi USA, LLC
$2.8912
per ML
OCTREOTIDE ACET 100 MCG/ML VL
Generic
68462089610•Glenmark Pharmaceuticals Inc., USA
$2.8912
per ML
OCTREOTIDE 1,000 MCG/5 ML VIAL
Generic
00641617701•Hikma Pharmaceuticals USA Inc.
$5.3404
per ML
OCTREOTIDE 1,000 MCG/5 ML VIAL
Generic
63323037805•Fresenius Kabi USA, LLC
$5.3404
per ML
OCTREOTIDE 1,000 MCG/ML VIAL
Generic
63323037905•Fresenius Kabi USA, LLC
$41.7580
per ML

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy